Antigen Presentation Pathway
SITC 2020 POSTER
Immunopeptidome changes mediated by a novel ERAP1 inhibitor lead to tumour growth inhibition.
Register to receive a copy of Grey Wolf’s poster presented at SITC 2020.
Please leave this field empty.
* I consent to giving the above information to Grey Wolf Therapeutics. I am aware my details will be saved for contact and marketing purposes.
Find out more.